The U.S. Army Medical Research Acquisition Activity has awarded a new contract for continued research and development of anti-parasitic drugs.
The contract to Lisa Xie is for conduct of the pharmacokinetics, efficacy and toxicity of antiparasitic drugs in animals for study of novel prophylactic and therapeutic drugs. The award is valued at $551,244.
Work will be performed at the Walter Reed Army Institute of Research in Silver Springs, Md.
As the largest Department of Defense biomedical research facility, WRAIR delivers life-saving products including knowledge, technology and medical material that sustain the combat effectiveness of servicemembers.
